These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29320563)

  • 21. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
    Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
    Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technology.
    Spackman E; Swayne DE
    Virus Res; 2013 Dec; 178(1):121-32. PubMed ID: 23524326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens.
    Oliveira Cavalcanti M; Vaughn E; Capua I; Cattoli G; Terregino C; Harder T; Grund C; Vega C; Robles F; Franco J; Darji A; Arafa AS; Mundt E
    Avian Pathol; 2017 Apr; 46(2):224-233. PubMed ID: 27807985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.
    Swayne DE; Spackman E; Pantin-Jackwood M
    Ecohealth; 2014; 11(1):94-108. PubMed ID: 24026475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a commercial inactivated H5 influenza vaccine against highly pathogenic avian influenza H5N1 in waterfowl evaluated under field conditions.
    Rudolf M; Pöppel M; Fröhlich A; Mettenleiter T; Beer M; Harder T
    Rev Sci Tech; 2009 Apr; 28(1):275-91. PubMed ID: 19618632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.
    Lee DH; Park JK; Kwon JH; Yuk SS; Erdene-Ochir TO; Jang YH; Seong BL; Lee JB; Park SY; Choi IS; Song CS
    PLoS One; 2013; 8(3):e58186. PubMed ID: 23469269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different cross protection scopes of two avian influenza H5N1 vaccines against infection of layer chickens with a heterologous highly pathogenic virus.
    Poetri ON; Van Boven M; Koch G; Stegeman A; Claassen I; Wayan Wisaksana I; Bouma A
    Res Vet Sci; 2017 Oct; 114():143-152. PubMed ID: 28411501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.
    Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G
    Front Immunol; 2019; 10():2006. PubMed ID: 31552018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of vaccination-induced immunity and antigenic distance in the transmission dynamics of highly pathogenic avian influenza H5N1.
    Sitaras I; Rousou X; Kalthoff D; Beer M; Peeters B; de Jong MC
    J R Soc Interface; 2016 Jan; 13(114):20150976. PubMed ID: 26763336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of antibody response to an epitope in the haemagglutinin subunit 2 of avian influenza virus H5N1 for differentiation of infected and vaccinated chickens.
    Putri K; Wibowo MH; Tarigan S; Wawegama N; Ignjatovic J; Noormohammadi AH
    Avian Pathol; 2020 Apr; 49(2):161-170. PubMed ID: 31738584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of immunity in commercial egg-laying hens following vaccination with a killed H6N2 avian influenza vaccine.
    Cardona CJ; Charlton BR; Woolcock PR
    Avian Dis; 2006 Sep; 50(3):374-9. PubMed ID: 17039836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Sitaras I; Rousou X; Peeters B; de Jong MCM
    Vaccine; 2016 Nov; 34(46):5512-5518. PubMed ID: 27729175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens.
    Rudolf M; Pöppel M; Fröhlich A; Breithaupt A; Teifke J; Blohm U; Mettenleiter T; Beer M; Harder T
    Vaccine; 2010 Oct; 28(42):6832-40. PubMed ID: 20727963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
    Worrall EE; Sudarisman ; Priadi A
    Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of avian influenza H5N1 virus from vaccinated commercial layer flock in Egypt.
    El-Zoghby EF; Arafa AS; Kilany WH; Aly MM; Abdelwhab EM; Hafez HM
    Virol J; 2012 Nov; 9():294. PubMed ID: 23185975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.
    Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Safwat M; Nawar AA; Erfan AM; Hassan MK; Aly MM; Hafez HM
    Vet Microbiol; 2011 May; 150(1-2):28-34. PubMed ID: 21236607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.